热门资讯> 正文
格林威治生命科学与意大利GIM联手
2024-11-26 19:20
- Clinical-stage biopharmaceutical Greenwich LifeSciences (NASDAQ:GLSI) announced its partnership with clinical sites in Italy.
- "Italy is the first country where we have personally visited and trained all of the sites participating in FLAMINGO-01. These sites are well located near large cities that will provide convenient access to patients. We are truly grateful for the time and commitment from our Italian colleagues." said CEO Snehal Patel.
More on Greenwich Lifesciences
- Seeking Alpha’s Quant Rating on Greenwich Lifesciences
- Historical earnings data for Greenwich Lifesciences
- Financial information for Greenwich Lifesciences
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
